Search

Merck Abandons Plans to Seek FDA Approval of Cholesterol Drug

MERCK ABANDONS PLANS TO SEEK FDA APPROVAL OF CHOLESTEROL DRUG

Merck is pulling the plug on a cholesterol-lowering drug that met its main goal in a clinical trial but still raised questions about...

 
 
 
KalVista, Merck Partnership on Blindness Drug Sends Shares Skyward

KALVISTA, MERCK PARTNERSHIP ON BLINDNESS DRUG SENDS SHARES SKYWARD

KalVista Pharmaceuticals has inked a partnership with pharmaceutical giant Merck for its lead drug, an experimental treatment for a...

Healthcare is Ready for Alexa, as Soon as HIPAA Issue Resolved

HEALTHCARE IS READY FOR ALEXA, AS SOON AS HIPAA ISSUE RESOLVED

A voice-enabled bathroom scale that can scan for diabetic foot ulcers uses Amazon's voice service, Alexa, to instruct patients to step...

 
 
 
Endocyte Adds Phase 3-Ready Prostate Cancer Drug with ABX Deal

ENDOCYTE ADDS PHASE 3-READY PROSTATE CANCER DRUG WITH ABX DEAL

Four months after two Endocyte drug candidates stumbled in early-stage studies, sparking a corporate shakeup, the company has signed...

 
 
 
Ex-Cubist CEO Bonney Emerges at Kaleido, Flagship's Latest Microbiome Startup

EX-CUBIST CEO BONNEY EMERGES AT KALEIDO, FLAGSHIP'S LATEST MICROBIOME STARTUP

Flagship Pioneering has been as active as any venture firm at funneling its investment dollars into microbiome drug developers. It's...

 
 
 
 
 
 

MERCK KGAA TO SELL $1 BILLION CONSUMER HEALTHCARE BIZ AFTER STRATEGIC REVIEW

Life Sciences Jobs ...

ONCOSEC APPOINTS INDUSTRY VETERAN ANNALISA JENKINS MBBS, FRCP TO BOARD OF DIRECTORS

Former Head of Global Research and Development for Merck Serono and Head of Global Medical Affairs of Bristol-Myers Squibb brings biopharma...

 
 
 
Bio Roundup: CAR-T's Huge Week, Merck's ‘Pib Choice & More

BIO ROUNDUP: CAR-T'S HUGE WEEK, MERCK'S ‘PIB CHOICE & MORE

The far-out idea of reprogramming a patient's immune cells to fight cancer, known as CAR-T, entered the mainstream this week, and two...

 
 
 
ANALYST: Most investors respect the Merck CEO's decision to resign from Trump's council

ANALYST: MOST INVESTORS RESPECT THE MERCK CEO'S DECISION TO RESIGN FROM TRUMP'S COUNCIL

Most investors respect Merck CEO Kenneth Frazier's decision to resign from US President Donald Trump's manufacturing council, a move...

 
 
 
Merck CEO takes a stand and resigns from Trump's Manufacturing Council

MERCK CEO TAKES A STAND AND RESIGNS FROM TRUMP'S MANUFACTURING COUNCIL

Frazier's departure leaves Johnson & Johnson CEO and Chairman Alex Gorsky as the one remaining executive from the pharma and medtech...

Intel and Under Armour are getting a brand boost after their executives walked out of Trump's manufacturing council

INTEL AND UNDER ARMOUR ARE GETTING A BRAND BOOST AFTER THEIR EXECUTIVES WALKED OUT OF TRUMP'S MANUFACTURING COUNCIL

Getty/Spencer Platt The president's manufacturing council of business leaders lost three of its members Monday , and a fourth on Tuesday. These...

 
 
 
From the son of a janitor to CEO of Merck: Meet Kenneth Frazier, who's getting praised after leaving Trump's manufacturing council

FROM THE SON OF A JANITOR TO CEO OF MERCK: MEET KENNETH FRAZIER, WHO'S GETTING PRAISED AFTER LEAVING TRUMP'S MANUFACTURING COUNCIL

Reuters Merck CEO Kenneth Frazier left the president's manufacturing council on Monday. The move attracted some negative attention...

3 CEOs have now quit Trump's manufacturing council over Charlottesville

3 CEOS HAVE NOW QUIT TRUMP'S MANUFACTURING COUNCIL OVER CHARLOTTESVILLE

REUTERS/Joshua Roberts New York - The chief executives of Merck, Intel and Under Armour resigned Monday from a White House advisory...